Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer
-
Published:2020-01
Issue:
Volume:139
Page:195-199
-
ISSN:0169-5002
-
Container-title:Lung Cancer
-
language:en
-
Short-container-title:Lung Cancer
Author:
Nakagawa Kazuhiko, Hida Toyoaki, Nokihara Hiroshi, Morise Masahiro, Azuma Koichi, Kim Young Hak, Seto Takashi, Takiguchi Yuichi, Nishio Makoto, Yoshioka HiroshigeORCID, Kumagai Toru, Hotta Katsuyuki, Watanabe SatoshiORCID, Goto Koichi, Satouchi Miyako, Kozuki ToshiyukiORCID, Koyama Ryo, Mitsudomi Tetsuya, Yamamoto Nobuyuki, Asakawa Takashi, Hayashi Morihiko, Hasegawa Wakako, Tamura Tomohide
Funder
A2 Healthcare Corporation AbbVie, AstraZeneca, Astellas, Bayer Yakuhin, Bristol-Myers Squibb, Chugai, CMIC Shift Zero, Daiichi Sankyo, Eisai, Eli Lilly, EPS Corporation, ICON Japan, IQVIA, Kissei, Kyowa Hakko Kirin, Merck Serono, Merck Sharp & Dohme, N ippon Boehringer Ingelheim Novartis Pharma, Ono, PAREXEL International, Pfizer, Quintiles, SymBio, Taiho, and Takeda; Clovis Oncology, Daiichi Sankyo, Dainippon Sumitomo, Eisai, Eli Lilly, Ignyta, Janssen, Servier, Taiho, and Takeda Bio; Chugai Pharmaceutical Co. Ltd
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference10 articles.
1. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology (NCCN Guidelines): Non-Small Cell Lung Cancer,2019 2. CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study;Seto;Lancet Oncol.,2013 3. Alectinib in crizotinib-refractory ALK-rearranged non-small-cell lung cancer: a phase II global study;Ou;J. Clin. Oncol.,2016 4. Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial;Shaw;Lancet Oncol.,2016 5. Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial;Hida;Lancet,2017
Cited by
94 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|